Bowen Hanes & CO Inc Novartis Ag Transaction History

Bowen Hanes & CO Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $380,121 - $429,991	-4,745 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$78.07 - $94.43 $268,170 - $324,367	-3,435 Reduced 41.99%	4,745 $448,000
Q3 2020 Feb 08, 2021	SELL	$82.14 - $91.0 $10,267 - $11,375	-125 Reduced 1.51%	8,180 $711,000
Q3 2020 Nov 02, 2020	SELL	$82.14 - $91.0 $82,140 - $91,000	-1,000 Reduced 10.75%	8,305 $722,000
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $64,015 - $72,060	-791 Reduced 7.83%	9,305 $813,000
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $70,670 - $99,010	1,000 Added 10.99%	10,096 $832,000
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $34,216 - $37,704	-400 Reduced 4.21%	9,096 $790,000
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $259,376 - $319,232	3,440 Added 56.8%	9,496 $867,000
Q1 2019 May 13, 2019	BUY	$75.32 - $86.15 $9,490 - $10,854	126 Added 2.12%	6,056 $582,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $332,943 - $370,730	-4,520 Reduced 43.25%	5,930 $509,000
Q3 2018 Nov 08, 2018	BUY	$66.94 - $77.43 $699,523 - $809,143	10,450 New	10,450 $900,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Bowen Hanes & CO Inc with notifications on news.